Sensodyne maker Haleon forecasts below-target 2026 growth on weak demand in US - Reuters

Reuters | Feb. 25, 2026, 2:19 a.m. | Original
Sensodyne maker Haleon forecasts below-target 2026 growth on weak demand in US Reuters
GSK to buy Canada's 35Pharma for $950 million - Reuters Iberdrola sees higher earnings after network business boosts 2025 results - Reuters